Why the study?
Frailty is seldom systematically assessed in HF patients, and guideline-directed medical treatment is under-prescribed despite greater absolute benefit, prompting discussion on multidimensional and multidisciplinary management.
Population
Heart failure patients with frailty
Design
Review
Key result
A comprehensive, multidimensional therapeutic strategy integrating pharmacological and non-pharmacological modalities is required to optimize outcomes in frail heart failure patients.
Authors
Loading...
May now guide individualized multidisciplinary HF care; leaves open outcome benefit of integrated strategies pending dedicated RCTs.
Frail heart failure patients require a comprehensive, multidimensional therapeutic strategy integrating pharmacological and non-pharmacological modalities across multiple disciplines.
Vitale et al. (2026) conducted a review in Heart failure with frailty. Multidimensional and multidisciplinary management was evaluated. A comprehensive, multidimensional therapeutic strategy integrating pharmacological and non-pharmacological modalities is required to optimize outcomes in frail heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: